The Taiwan Centers for Disease Control (CDC) stated that from June 4 to June 10, there were 328 new confirmed local COVID-19 cases (including complications) in the country, an increase from the previous week's 263 cases (May 28 to June 3). Among the accumulated cases with complications, elderly individuals aged 65 and above accounted for 79%. Additionally, there were 20 new deaths reported last week, a decrease from 26 the week before, with elderly individuals aged 65 and above comprising 90% of the cumulative fatalities. The situation is assessed to be escalating and entering an epidemic phase.

The Taiwan Centers for Disease Control (CDC) reported that up to now, a total of 2.764 million doses of the COVID-19 XBB vaccine have been administered domestically, with a national vaccination rate of 11.36%. Among those aged 65 and above, the first dose coverage is 20.54%, and the second dose coverage is 1.55%. Currently, there are approximately 2.889 million doses of the Moderna XBB vaccine and about 48,000 doses of the Novavax XBB vaccine still available nationwide. Due to the ongoing epidemic situation, the CDC urges those who have not yet received the COVID-19 XBB vaccine not to underestimate the threat of the disease and to get vaccinated as soon as possible.

According to surveillance data from the Taiwan Centers for Disease Control (CDC) over the past four weeks, the monitoring of variant strains shows that both local and imported cases are predominantly JN.1, accounting for 64% and 59% respectively, with a recent slight decline. Additionally, the proportions of KP.2 and KP.3 have slightly increased, with KP.2 accounting for 10% and 22% respectively, and KP.3 at 9% each. Continued monitoring of the trend in variant strain prevalence is ongoing.

The Taiwan Centers for Disease Control (CDC) reminds the public that due to ongoing transmission risks, individuals experiencing symptoms such as fever, cough, runny nose, or sore throat should use home rapid antigen test kits first and inform healthcare providers of the test results when seeking medical attention. Furthermore, vaccination with COVID-19 XBB vaccines remains the most effective method to reduce the risk of severe illness or death post-infection. People aged 6 months and older are urged to get vaccinated as soon as possible.

For individuals aged 65 and above, those with immunodeficiency or weakened immune systems, it is recommended that those who have already received their first dose and have waited 12 weeks (84 days) should receive their second dose to enhance protection. This applies to high-risk groups such as individuals aged 65 and above, Indigenous people aged 55-64, and those aged 6 months and above with immunodeficiency or weakened immune systems. This second dose helps to lower the chances of severe illness or death. Information on vaccination locations can be found on the CDC's official website under the "COVID-19/Coronavirus Vaccine Zone.